QinetiQ Group PLC — Investor Relations & Filings
QinetiQ Group PLC is a science and engineering company that provides technology-based products and services primarily to the global defence and security sectors. The company's core activities include research and development, advisory services, and comprehensive test and evaluation (T&E) for air, land, and maritime systems. Key offerings encompass uncrewed air, land, and surface target systems for live-fire training and weapons system assessment; cybersecurity services and training; and advanced training and mission rehearsal solutions. QinetiQ focuses on mission-led innovation, applying its expertise to modernize military platforms and enhance critical technologies to address complex operational challenges for its customers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Transaction in Own Shares | 2026-05-26 | English | |
| QinetiQ Full Year Results 2026 | 2026-05-21 | English | |
| QinetiQ Full Year Results 2026 | 2026-05-21 | English | |
| Holding(s) in Company | 2026-05-20 | English | |
| Holding(s) in Company | 2026-05-19 | English | |
| Transaction in Own Shares | 2026-05-19 | English |
Browse filings by year
24 years- 2026 84 filings
- 2025 305 filings
- 2024 258 filings
- 2023 51 filings
- 2022 56 filings
- 2021 51 filings
- 2020 54 filings
- 2019 42 filings
- 2018 80 filings
- 2017 66 filings
- 2016 131 filings
- 2015 201 filings
- 2014 218 filings
- 2013 55 filings
- 2012 7 filings
- 2011 6 filings
- 2010 1 filing
- 2009 1 filing
- 2008 1 filing
- 2007 1 filing
- 2006 2 filings
- 2005 1 filing
- 2004 1 filing
- 2003 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47051860 | Transaction in Own Shares | 2026-05-26 | English | ||
| 46723136 | QinetiQ Full Year Results 2026 | 2026-05-21 | English | ||
| 46715781 | QinetiQ Full Year Results 2026 | 2026-05-21 | English | ||
| 46681305 | Holding(s) in Company | 2026-05-20 | English | ||
| 46545915 | Holding(s) in Company | 2026-05-19 | English | ||
| 46524217 | Transaction in Own Shares | 2026-05-19 | English | ||
| 45332153 | Director/PDMR Shareholding | 2026-05-12 | English | ||
| 45118820 | Transaction in Own Shares | 2026-05-12 | English | ||
| 41305975 | Transaction in Own Shares | 2026-05-05 | English | ||
| 39110066 | Total Voting Rights | 2026-04-30 | English | ||
| 37867061 | Transaction in Own Shares | 2026-04-28 | English | ||
| 34696665 | Transaction in Own Shares | 2026-04-21 | English | ||
| 34655068 | Transaction in Own Shares | 2026-04-14 | English | ||
| 34088310 | Director/PDMR Shareholding | 2026-04-10 | English | ||
| 33558607 | Director/PDMR Shareholding | 2026-04-01 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for QinetiQ Group PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMAGION BIOSYSTEMS LIMITED
Develops nanoparticle-based imaging for non-invasive cancer…
|
IBX | AU | Professional, scientific and te… |
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
QinetiQ Group PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4849/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4849 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4849 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4849 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4849}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for QinetiQ Group PLC (id: 4849)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.